Skip to content

Myopia Control Using Optimized Optical Defocus RCTs

Myopia Control Using Optimized Optical Defocus in Schoolchildren - a Randomized Double Masked Control Trial

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03681366
Enrollment
167
Registered
2018-09-24
Start date
2018-10-25
Completion date
2022-06-24
Last updated
2022-08-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Myopia

Keywords

myopia, Myopic Defocus, contact lens, myopia control

Brief summary

The aims of the study is to evaluate whether the DISC3.5 Plus contact lens will slow myopia progression and axial length growth in myopic children as compared with single vision soft contact lenses.

Detailed description

The purpose of the current study is to evaluate whether the DISC3.5 Plus contact lens will slow myopia progression and axial length growth in myopic children as compared with single vision soft contact lenses. The Defocus Incorporated Soft 3.5 Plus Contact Lens (DISC3.5 Plus) is a soft contact lens that comprises of simultaneous distance optical prescription and myopic defocus areas. The efficacy of the DISC3.5 Plus lens in slowing myopia progression (change in refractive error) will be compared to a spherical (front and back surface) single vision soft contact lenses in this one-year prospective, randomised and double-masked clinical trial. The hypothesis of this study is that the DISC3.5 Plus will slow myopia progression more than spherical single vision soft contact lenses.

Interventions

DEVICEDISC3.5 plus

The Defocus Incorporated Soft 3.5 Plus Contact Lens (DISC3.5 Plus) is a soft contact lens that comprises of simultaneous distance optical prescription and myopic defocus areas.

Sponsors

The Hong Kong Polytechnic University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
DOUBLE (Subject, Investigator)

Masking description

Double masked design: The investigator(s) who were responsible for refracting and performing relevant ocular data measurement were masked from the grouping of the subjects. The unmasked investigator(s) were responsible for group allocation, spectacle-dispensing work, measuring lens visual performance, record keeping, data entry and compliance checking. Data input was carefully checked by the unmasked investigator and the other researchers independently. The children and their parents were also masked to group allocation until the data analysis was completed.

Eligibility

Sex/Gender
ALL
Age
8 Years to 13 Years
Healthy volunteers
Yes

Inclusion criteria

* Age at enrolment: 8-13 year; Hong Kong Chinese * Spherical equivalent refractions (SER): -1.00 to -5.00D * Astigmatism: -1.00D or less * Anisometropia: 1.25D or less * Spectacle corrected monocular visual acuity (VA): 0.0 logMAR or better * Contact lens corrected monocular VA: 0.1 logMAR or better * Normal binocular function * Willingness to wear contact lenses regularly * Parents' understanding and acceptance of random allocation of grouping and masking

Exclusion criteria

* Prior myopia control treatment, e.g. orthokeratology, defocus soft contact lenses, progressive addition lenses, bifocal lenses, drugs (e.g. atropine), etc. * Strabismus or decompensated phoria (checked by cover test at far and near in screening) * Known contraindications for contact lens wear * Have any ocular and systemic diseases and abnormalities that might affect visual function or refractive development

Design outcomes

Primary

MeasureTime frameDescription
Cycloplegic Refraction Change in SER12 monthsChange in cycloplegic autorefraction in spherical equivalent (SER)

Secondary

MeasureTime frameDescription
Axial length12 monthsAxial length (mm) was measured after cycloplegia

Countries

China

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026